The insulin gene mutation c.137G>A (R46Q), which changes an arginine at the B22 position of the mature hormone to glutamine, causes the monogenic diabetes variant maturity-onset diabetes of the young (MODY). In MODY patients, this mutation is heterozygous, and both mutant and wild-type (WT) human insulin are produced simultaneously. However, the patients often depend on administration of exogenous insulin. In this study, we chemically synthesized the MODY mutant [GlnB22]-insulin and characterized its biological and structural properties. The chemical synthesis of this insulin analogue revealed that its folding ability is severely impaired. In vitro and in vivo tests showed that its binding affinity and biological activity are reduced (both approximately 20% that of human insulin). Comparison of the solution structure of [GlnB22]-insulin with the solution structure of native human insulin revealed that the most significant structural effect of the mutation is distortion of the B20-B23 β-turn, leading to liberation of the B chain C-terminus from the protein core. The distortion of the B20-B23 β-turn is caused by the extended conformational freedom of the GlnB22 side chain, which is no longer anchored in a hydrogen bonding network like the native ArgB22. The partially disordered [GlnB22]-insulin structure appears to be one reason for the reduced binding potency of this mutant and may also be responsible for its low folding efficiency in vivo. The altered orientation and flexibility of the B20-B23 β-turn may interfere with the formation of disulfide bonds in proinsulin bearing the R46Q (GlnB22) mutation. This may also have a negative effect on the WT proinsulin simultaneously biosynthesized in β-cells and therefore play a major role in the development of MODY in patients producing [GlnB22]-insulin.

Institute of Organic Chemistry and Biochemistry Academy of Sciences of the Czech Republic v v i Flemingovo nám 2 166 10 Prague 6 Czech Republic

York Structural Biology Laboratory Department of Chemistry The University of York Heslington York YO10 5DD United Kingdom

Zobrazit více v PubMed

Steck AK, Winter WE (2011) Review on monogenic diabetes. Curr Opin Endocrinol Diabetes Obes 18:252–258. PubMed

McDonald TJ, Ellard S (2013) Maturity onset diabetes of the young: identification and diagnosis. Ann Clin Biochem 50:403–415. PubMed

Fajans SS, Bell GI, Polonsky KS (2001) Mechanisms of disease: Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 345:971–980. PubMed

Baker EN, Blundell TL, Cutfield JF, Cutfield SM, Dodson EJ, et al. (1988) The structure of 2Zn pig insulin crystals at 1.5 A resolution. Philos Trans R Soc Lond B Biol Sci 319:369–456. PubMed

Steiner DF, Chan SJ, Welsh JM, Kwok SC (1985) Structure and evolution of the insulin gene. Annu Rev Genet 19:463–484. PubMed

Nishi M, Nanjo K (2011) Insulin gene mutations and diabetes. J Diabetes Investig 2:92–100. PubMed PMC

Jiracek J, Zakova L, Antolikova E, Watson CJ, Turkenburg JP, et al. (2010) Implications for the active form of human insulin based on the structural convergence of highly active hormone analogues. Proc Natl Acad Sci U S A 107:1966–1970. PubMed PMC

Zakova L, Barth T, Jiracek J, Barthova J, Zorad S (2004) Shortened insulin analogues: Marked changes in biological activity resulting from replacement of TyrB26 and N-methylation of peptide bonds in the C-terminus of the B-chain. Biochemistry 43:2323–2331. PubMed

Zakova L, Kazdova L, Hanclova I, Protivinska E, Sanda M, et al. (2008) Insulin analogues with modifications at position B26. Divergence of binding affinity and biological activity. Biochemistry 47:5858–5868. PubMed

Antolikova E, Zakova L, Turkenburg JP, Watson CJ, Hanclova I, et al. (2011) Non-equivalent Role of Inter- and Intramolecular Hydrogen Bonds in the Insulin Dimer Interface. J Biol Chem 286:36968–36977. PubMed PMC

Zakova L, Kletvikova E, Veverka V, Lepsik M, Watson CJ, et al. (2013) Structural integrity of the B24 site in human insulin is important for hormone functionality. J Biol Chem 288:10230–10240. PubMed PMC

Mirmira RG, Nakagawa SH, Tager HS (1991) Importance of the character and configuration of residues B24, B25, and B26 in insulin-receptor interactions. J Biol Chem 266:1428–1436. PubMed

Nakagawa SH, Tager HS, Steiner DF (2000) Mutational analysis of invariant valine B12 in insulin: implications for receptor binding. Biochemistry 39:15826–15835. PubMed

Brange J, Ribel U, Hansen JF, Dodson G, Hansen MT, et al. (1988) Monomeric insulins obtained by protein engineering and their medical implications. Nature 333:679–682. PubMed

Slieker LJ, Brooke GS, DiMarchi RD, Flora DB, Green LK, et al. (1997) Modifications in the B10 and B26–30 regions of the B chain of human insulin alter affinity for the human IGF-I receptor more than for the insulin receptor. Diabetologia 40 Suppl 2 S54–S61. PubMed

Mayer JP, Zhang F, DiMarchi RD (2007) Insulin Structure and Function. Biopolymers (Peptide Science) 88:687–713. PubMed

Kristensen C, Kjeldsen T, Wiberg FC, Schaffer L, Hach M, et al. (1997) Alanine scanning mutagenesis of insulin. J Biol Chem 272:12978–12983. PubMed

Edghill EL, Flanagan SE, Patch AM, Boustred C, Parrish A, et al. (2008) Insulin mutation screening in 1,044 patients with diabetes: Mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood. Diabetes 57:1034–1042. PubMed PMC

Stoy J, Edghill EL, Flanagan SE, Ye HG, Paz VP, et al. (2007) Insulin gene mutations as a cause of permanent neonatal diabetes. Proc Natl Acad Sci U S A 104:15040–15044. PubMed PMC

Stoy J, Steiner DF, Park SY, Ye HG, Philipson LH, et al. (2010) Clinical and molecular genetics of neonatal diabetes due to mutations in the insulin gene. Rev Endocr Metab Disord 11:205–215. PubMed PMC

Tager H, Thomas N, Assoian R, Rubenstein A, Saekow M, et al. (1980) Semisynthesis and biological activity of porcine [LeuB24]insulin and [LeuB25]insulin. Proc Natl Acad Sci U S A 77:3181–3185. PubMed PMC

Menting JG, Whittaker J, Margetts MB, Whittaker LJ, Kong GKW, et al. (2013) How insulin engages its primary binding site on the insulin receptor. Nature 493:241–245. PubMed PMC

Zakova L, Kletvikova E, Lepsik M, Collinsova M, et al. (2014) Human insulin analogues modified at the B26 site reveal a hormone conformation that is undetected in the receptor complex. Acta Crystallogr D70:2765–2774. PubMed PMC

Menting JG, Yang Y, Chan SJ, Phillips NB, Smith BJ, et al. (2014) Protective hinge in insulin opens to enable its receptor engagement. Proc Natl Acad Sci U S A 111:E3395–3404. PubMed PMC

Molven A, Ringdal M, Nordbo AM, Raeeder H, Stoy J, et al. (2008) Mutations in the insulin gene can cause MODY and autoantibody-negative type 1 diabetes. Diabetes 57:1131–1135. PubMed

Boesgaard TW, Pruhova S, Andersson EA, Cinek O, Obermannova B, et al. (2010) Further evidence that mutations in INS can be a rare cause of Maturity-Onset Diabetes of the Young (MODY). BMC Med Genet 11. PubMed PMC

Kosinova L, Veverka V, Novotna P, Collinsova M, Urbanova M, et al. (2014) Insight into the Structural and Biological Relevance of the T/R Transition of the N-Terminus of the B-Chain in Human Insulin. Biochemistry 53:3392–3402. PubMed PMC

Morcavallo A, Genua M, Palummo A, Kletvikova E, Jiracek J, et al. (2012) Insulin and Insulin-like Growth Factor II Differentially Regulate Endocytic Sorting and Stability of Insulin Receptor Isoform A. J Biol Chem. 287:11422–11436. PubMed PMC

Herrmann T, Guntert P, Wuthrich K (2002) Protein NMR structure determination with automated NOE assignment using the new software CANDID and the torsion angle dynamics algorithm DYANA. J Mol Biol 319:209–227. PubMed

Shen Y, Delaglio F, Cornilescu G, Bax A (2009) TALOS+: a hybrid method for predicting protein backbone torsion angles from NMR chemical shifts. J Biomol NMR 44:213–223. PubMed PMC

Guntert P, Wuthrich K (1991) Improved efficiency of protein structure calculations from NMR data using the program DIANA with redundant dihedral angle constraints. J Biomol NMR 1:447–456. PubMed

Harjes E, Harjes S, Wohlgemuth S, Muller KH, Krieger E, et al. (2006) GTP-Ras disrupts the intramolecular complex of C1 and RA domains of Nore1. Structure 14:881–888. PubMed

Koradi R, Billeter M, Wuthrich K (1996) MOLMOL: A program for display and analysis of macromolecular structures. J Mol Graphics 14:51–55. PubMed

Doreleijers JF, da Silva AWS, Krieger E, Nabuurs SB, Spronk CAEM, et al. (2012) CING: an integrated residue-based structure validation program suite. J Biomol NMR 54:267–283. PubMed PMC

Chang SG, Kim DY, Choi KD, Shin JM, Shin HC (1998) Human insulin production from a novel mini-proinsulin which has high receptor-binding activity. Biochem J 329:631–635. PubMed PMC

De Meyts P (1976) Insulin and growth hormone receptors in human cultured lymphocytes and peripheral blood monocytes. Methods in Receptor Research. New York: M.Dekker. pp. 301–383.

Hua QX, Gozani SN, Chance RE, Hoffmann JA, Frank BH, et al. (1995) Structure of a protein in a kinetic trap. Nat Struct Biol 2:129–138. PubMed

Zimmerman AE, Yip CC (1974) Guinea-Pig Insulin.1. Purification and Physical-Properties. J Biol Chem 249:4021–4025. PubMed

Horuk R, Blundell TL, Lazarus NR, Neville RWJ, Stone D, et al. (1980) A Monomeric Insulin from the Porcupine (Hystrix-Cristata), an Old-World Hystricomorph. Nature 286:822–824. PubMed

Du HJ, Shi JH, Cui DF, Zhang YS (2006) B22 Glu des-b30 insulin: A novel monomeric insulin. Acta Biochim Biophys Sin 38:537–542. PubMed

Zhu SQ, Li TF, Cui DF, Cao QP, Zhang YS (1981) Effect of B22-arginine replacement on the biological activity of insulin. Sci Sin 24:264–271. PubMed

Katsoyannis PG, Ginos J, Cosmatos A, Schwartz GP (1975) A synthetic human insulin analogue midified at position B-22. [Lys-22- B] human insulin. J Chem Soc [Perkin 1]: 464–466. PubMed

Wang SH, Hu SQ, Burke GT, Katsoyannis PG (1991) Insulin analogues with modifications in the beta-turn of the B-chain. J Protein Chem 10:313–324. PubMed

Mirmira RG, Tager HS (1989) Role of the phenylalanine B24 side chain in directing insulin interaction with its receptor. Importance of main chain conformation [published erratum appears in J Biol Chem 1989 Oct 15; 264(29): 17613]. J Biol Chem 264:6349–6354. PubMed

Weitzel G, Bauer FU, Rehe Z (1977) Structure and activity of insulin, XV[1–5]. Further evidence for the importance of arginine residue B22 in the activity of insulin. Semisyntheses of despentapeptide. Hoppe Seylers Z Physiol Chem 358:1573–1582. PubMed

Jonassen I, Havelund S, Hoeg-Jensen T, Steensgaard DB, Wahlund PO, et al. (2012) Design of the Novel Protraction Mechanism of Insulin Degludec, an Ultra-long-Acting Basal Insulin. Pharm Res 29:2104–2114. PubMed PMC

Kalra S, Unnikrishnan AG, Baruah M, Kalra B (2011) Degludec insulin: A novel basal insulin. Indian J Endocrinol Metab 15:S12–16. PubMed PMC

Marki F, de Gasparo M, Eisler K, Kamber B, Riniker B, et al. (1979) Synthesis and biological activity of seventeen analogues of human insulin. Hoppe Seylers Z Physiol Chem 360:1619–1632. PubMed

Ribel U, Hougaard P, Drejer K, Sorensen A (1990) Equivalent in vivo biological activity of insulin analogues and human insulin despite different in vitro potencies. Diabetes 39:1033–1039. PubMed

Liu M, Haataja L, Wright J, Wickramasinghe NP, Hua QX, et al. (2010) Mutant INS-Gene Induced Diabetes of Youth: Proinsulin Cysteine Residues Impose Dominant-Negative Inhibition on Wild-Type Proinsulin Transport. Plos One 5:e13333. PubMed PMC

Zoete V, Meuwly M (2006) Importance of individual side chains for the stability of a protein fold: Computational alanine scanning of the insulin monomer. J Comput Chem 27:1843–1857. PubMed

Kurapkat G, De Wolf E, Grotzinger J, Wollmer A (1997) Inactive conformation of an insulin despite its wild-type sequence. Protein Sci 6:580–587. PubMed PMC

Ludvigsen S, Olsen HB, Kaarsholm NC (1998) A structural switch in a mutant insulin exposes key residues for receptor binding. J Mol Biol 279:1–7. PubMed

Mutations at hypothetical binding site 2 in insulin and insulin-like growth factors 1 and 2 result in receptor- and hormone-specific responses